Erythromycin resistance in Streptococcus pyogenes in Italy

M Bassetti1, G Manno, A Collidà

  • 1Infectious Diseases Department, University of Genoa, G. Gaslini Children's Hospital, Genoa, Italy. mattba@tin.it

Insights

Macrolide resistance in Streptococcus pyogenes impacts treatment success for acute pharyngitis in children. Erythromycin-resistant strains showed lower eradication rates with clarithromycin, indicating treatment failure.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Pharmacology

Background:

  • Acute pharyngitis is a common childhood illness.
  • Streptococcus pyogenes is a primary bacterial cause of acute pharyngitis.
  • Antibiotic resistance, particularly to macrolides, is a growing concern.

Purpose of the Study:

  • To investigate the prevalence of macrolide resistance in Streptococcus pyogenes causing acute pharyngitis in Italian children.
  • To evaluate the clinical effectiveness of clarithromycin in treating S. pyogenes infections based on macrolide susceptibility.
  • To identify factors associated with treatment failure.

Main Methods:

  • Prospective study design.
  • Isolates of Streptococcus pyogenes collected from children with acute pharyngitis.
  • Macrolide susceptibility testing performed on bacterial isolates.
  • Clinical outcomes assessed following clarithromycin treatment.

Main Results:

  • 38.3% of 180 Streptococcus pyogenes isolates were resistant to macrolides.
  • Clarithromycin eradicated S. pyogenes in 63.1% of patients with erythromycin-resistant strains (n=19).
  • Eradication rates were higher (88%) in patients with erythromycin-susceptible strains (n=25).
  • Constitutive macrolide resistance phenotype correlated with treatment failure.

Conclusions:

  • Macrolide resistance in Streptococcus pyogenes is prevalent in Italian children with acute pharyngitis.
  • Clarithromycin effectiveness is significantly reduced in the presence of erythromycin-resistant S. pyogenes.
  • The constitutive-resistant phenotype is a predictor of macrolide treatment failure in pediatric pharyngitis.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...